Cubit Hc. - search results

European Union - English - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - heart failure - angiotensin ii antagonists, other combinations, agents acting on the renin-angiotensin system - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction.adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

European Union - English - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, valsartan - heart failure - agents acting on the renin-angiotensin system - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5.1).adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.1).

Philippines - English - FDA (Food And Drug Administration)

vymada film-coated tablet

novartis healthcare philippines, inc.; distributor: novartis healthcare philippines, inc. - sacubitril-valsartan - film-coated tablet - 100mg (eq. to sacubitril 48.6mg and valsartan 51.4mg sodium salt complex)

Philippines - English - FDA (Food And Drug Administration)

vymada film-coated tablet

novartis healthcare philippines, inc.; distributor: novartis healthcare philippines, inc. - sacubitril-valsartan - film-coated tablet - 200mg (eq. to sacubitril 97.2mg and valsartan 102.8mg sodium salt complex)